Back to search results

LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Kidney Injury · Cardiac Surgery

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Cumming School of Medicine & Libin Cardiovascular Centre, University of Calgary, Calgary, Alberta, Canada

    Contact: Study coordinator (Alexander J Gregory) · alex.gregory@albertahealthservices.ca · 403 944 1539

  • Royal Columbian Hospital, New Westminster, British Columbia, Canada

    Contact: Study coordinator (Derek Gunning) · 604-522-6800

  • Unity Health Toronto, St. Michael's Hospital, Toronto, Ontario, Canada

    Contact: Study coordinator (David Mazer) · david.mazer@unityhealth.to · 416 864 6060

  • University Health Network, Toronto General Hospital, Toronto, Ontario, Canada

    Contact: Study coordinator (Keyvan Karkouti) · keyvan.karkouti@uhn.ca · 416 340 3698

  • Gazi University, Yenimahalle, Ankara, Turkey (Türkiye)

  • Kosuyolu High Specialization Training and Research Hospital, Kartal, Istanbul, Turkey (Türkiye)

  • Erciyes University, Faculty of Medicine - Semiha Kibar Organ Transplant & Dialysis Hospital, Melikgazi, Kayseri, Turkey (Türkiye)

  • Kocaeli University, Faculty of Medicine Practices and Research Hospital, İzmit, Kocaeli, Turkey (Türkiye)

  • Sütçü İmam University, Faculty of Medicine, Kahramanmaraş, Onikişubat, Turkey (Türkiye)

View source on ClinicalTrials.gov(opens in a new tab)